www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News 9 killed in bomb explosion in E. Baghdad    Urgent: Strong earthquake strikes near Tonga     Urgent: New Security Council resolution tabled demanding Iran suspend enrichment    Urgent: France, Britain to table new resolution on Iran    Urgent: Major earthquake hits Tonga region of Pacific    Urgent: 9/11 conspirator sentenced to life in prison    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
New antibiotic tackling multi-resistant germs found
www.chinaview.cn 2006-05-04 19:03:51

    LONDON, May 4 (Xinhua) -- German scientists have discovered a novel and natural substance that inhibits the growth of multi-resistant germs, according to the latest report on the website of AlphaGalileo.

    This new substance, which goes by the name MMA, or 7-O-malonyl-macrolactin A, has proven effective against several multi-resistant germs, which is a new hope in the battle against bacterial pathogens resistant to "last line of defense" drugs, the report said.

    The new antibiotic, discovered by scientists at the German Research Centre for Biotechnology (GBF) in Braunschweig through a research program to explore new microbial diversity for new drugs, is produced by a new strain of the soil bacterium Bacillus subtilis, the report quoted GBF scientists as saying.

    The new antibiotic not only inhibits the notorious strain of methicillin-resistant Staphylococcus aureus (MRSA), but also vancomycin-resistant enterococci (VRE), both of which cause potentially lethal infections in hospitalized patients, GBF scientists said, adding the antibiotic MMA inhibits cell division by the bacteria, so they are unable to divide and spread.

    GBF scientists see a promising future for the new antibiotic, but they said however it would take a few more years before it is known whether the MMA can find its way into the clinic for human use as the substance needs to be studied more closely, thoroughly tested and ultimately clinically tried. Enditem

Editor: Lin Li
  Related Story  
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.